The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Nanoparticles - A review
Open accessAbstract
For the past few decades, there has been a considerable research interest in the area of drug delivery using particulate delivery systems as carriers for small and large molecules. Particulate systems like nanoparticles have been used as a physical approach to alter and improve the pharmacokinetic and pharmacodynamic properties of various types of drug molecules. They have been used in vivo to protect the drug entity in the systemic circulation, restrict access of the drug to the chosen sites and to deliver the drug at a controlled and sustained rate to the site of action. Various polymers have been used in the formulation of nanoparticles for drug delivery research to increase therapeutic benefit, while minimizing side effects. Here, we review various aspects of nanoparticle formulation, characterization, effect of their characteristics and their applications in delivery of drug molecules and therapeutic genes. Keywords: nanoparticles, drug delivery, targeting, drug release > Tropical Journal of Pharmaceutical Research Vol. 5 (1) 2006: pp. 561-573
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Completely “Green” Synthesis and Stabilization of Metal Nanoparticles
Raveendran, P., Fu, J., & Wallen, S. L. (2003) · Journal of the American Chemical Society · doi:10.1021/ja029267j · Cited by 2,303
Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
The Scattering of Light and the Radial Distribution Function of High Polymer Solutions
Zimm, B. H. (1948) · The Journal of Chemical Physics · doi:10.1063/1.1746738 · Cited by 1,549
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., Lee, J. H., Andrade, J. D., & De Gennes, P. G. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90043-8 · Cited by 1,523
Zimm, B. H. (1948) · The Journal of Chemical Physics · doi:10.1063/1.1746740 · Cited by 1,442
Light scattering and the absolute characterization of macromolecules
Wyatt, P. J. (1993) · Analytica Chimica Acta · doi:10.1016/0003-2670(93)80373-s · Cited by 1,436
Particle design using supercritical fluids: Literature and patent survey
Jung, J., & Perrut, M. (2001) · The Journal of Supercritical Fluids · doi:10.1016/s0896-8446(01)00064-x · Cited by 1,141
ULTRASOUND: Its Chemical, Physical and Biological Effects
Suslick, K. S., & Nyborg, W. L. (1990) · The Journal of the Acoustical Society of America · doi:10.1121/1.398864 · Cited by 1,094
Einstein, A., & Infeld, L. (1938) · University Press eBooks · Cited by 1,068
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858
Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials
Rolland, J. P., Maynor, B. W., Euliss, L. E., Exner, A. E., Denison, G. M., & DeSimone, J. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051977c · Cited by 852
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Biomaterials in Drug Delivery and Tissue Engineering: One Laboratory's Experience
Langer, R. (2000) · Accounts of Chemical Research · doi:10.1021/ar9800993 · Cited by 750
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
(2007) · Wiley eBooks · doi:10.1002/9783527621323 · Cited by 717
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., & Andrade, J. D. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90044-9 · Cited by 589
Nanomaterials and supercritical fluids
Reverchon, E., & Adami, R. (2006) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2005.08.003 · Cited by 589
Nanocapsule Technology: A Review
Couvreur, P., Barratt, G., Fattal, E., & Vauthier, C. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.10 · Cited by 555
Design of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Zambaux, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00106-5 · Cited by 537
Panyam, J., Dali, M. M., Sahoo, S. K., Ma, W., Chakravarthi, S. S., Amidon, G. L., Levy, R. J., & Labhasetwar, V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00328-6 · Cited by 529
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Ravi Kumar, M. N. V., Bakowsky, U., & Lehr, C. M. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.069 · Cited by 492
Niwa, T., Takeuchi, H., Hino, T., Kunou, N., & Kawashima, Y. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90097-o · Cited by 483
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Colloidal Drug Delivery Systems
Kreuter, J. (2014) · CRC Press eBooks · doi:10.1201/9781498710565 · Cited by 469
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Dunne, M., Corrigan, O. I., & Ramtoola, Z. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00040-5 · Cited by 444
Drug transport to brain with targeted nanoparticles
Olivier, J.-C. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.108 · Cited by 444
Drug and gene targeting to the brain with molecular trojan horses
Pardridge, W. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd725 · Cited by 439
Redhead, H. M., Davis, S. S., & Illum, L. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00367-9 · Cited by 419
Colloidal drug delivery systems
Duncan-Hewitt, W. C. (1995) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/0927-7765(95)90010-1 · Cited by 419
Penetration and enzymatic barriers to peptide and protein absorption
Lee, V. H. L., & Yamamoto, A. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90018-5 · Cited by 413
In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
Zauner, W., Farrow, N. A., & Haines, A. M. R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00358-8 · Cited by 411
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06377.x · Cited by 394
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain
Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 362
Panyam, J., Williams, D., Dash, A., Leslie‐Pelecky, D., & Labhasetwar, V. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20094 · Cited by 320
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas
Florence, A. T., & Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00184-3 · Cited by 308
Pharmacokinetics and distribution of a biodegradable drug-carrier
Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., & Speiser, P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305
Oyewumi, M. O., Yokel, R. A., Jay, M., Coakley, T., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.002 · Cited by 296
The Scattering of Light and its Applications to Chemistry.
Oster, G. (1948) · Chemical Reviews · doi:10.1021/cr60135a005 · Cited by 289
Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method
Kwon, H.-Y., Lee, J.-Y., Choi, S.-W., Jang, Y., & Kim, J.-H. (2001) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(00)00825-6 · Cited by 286
Chitosans as absorption enhancers of poorly absorbable drugs
Schipper, N. G. M., Vårum, K. M., Stenberg, P., Ocklind, G., Lennernäs, H., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00032-9 · Cited by 278
Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery
Lee, M., & Kim, S. W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9003-5 · Cited by 277
Peracchia, M. T., Gref, R., Minamitake, Y., Domb, A., Lotan, N., & Langer, R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01597-0 · Cited by 266
DNA vaccines: a key for inducing long-term cellular immunity
Gurunathan, S., Wu, C.-Y., Freidag, B. L., & Seder, R. A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00118-7 · Cited by 261
Magenheim, B., Levy, M. Y., & Benita, S. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90015-8 · Cited by 250
Nanocapsules as carriers for oral peptide delivery
Damgé, C., Michel, C., Aprahamian, M., Couvreur, P., & Devissaguet, J. P. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90013-j · Cited by 245
Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses
Hedley, M. L., Curley, J., & Urban, R. (1998) · Nature Medicine · doi:10.1038/nm0398-365 · Cited by 235
Defining the drug incorporation properties of PLA–PEG nanoparticles
Govender, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00375-6 · Cited by 225
Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat
Hussain, N., Jani, P. U., & Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012153011884 · Cited by 191
Lehr, C.-M., Bouwstra, J. A., Tukker, J. J., & Junginger, H. E. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90074-4 · Cited by 185
Pegnology: a review of PEG-ylated systems.
Bhadra, D., Bhadra, S., Jain, P., & Jain, N. K. (2002) · PubMed · Cited by 183
Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Chen, Y., Mohanraj, V. J., & Parkin, J. E. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442596 · Cited by 166
Self-citationPharmacokinetics and brain uptake of lactoferrin in rats
Ji, B., Maeda, J., Higuchi, M., Inoue, K., Akita, H., Harashima, H., & Suhara, T. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.05.085 · Cited by 166
Drug Delivery Across the Blood-Brain Barrier
Chen, Y., Dalwadi, G., & Benson, H. (2004) · Current Drug Delivery · doi:10.2174/1567201043334542 · Cited by 162
Self-citationZhang, Q., Shen, Z., & Nagai, T. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00614-7 · Cited by 159
Tissue Distribution of Antitumor Drugs Associated with Polyalkylcyanoacrylate Nanoparticles
Couvreur, P., Kante, B., Lenaerts, V., Scailteur, V., Roland, M., & Speiser, P. P. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690222 · Cited by 152
Fresta, M., Puglisi, G., Giammona, G., Cavallaro, G., Micali, N. L., & Furneri, P. M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840721 · Cited by 152
Steric stabilization of nanoparticles: Size and surface properties
Lourenço, C. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04486-9 · Cited by 149
Long-Circulating Polymeric Nanovectors for Tumor-Selective Gene Delivery
Kommareddy, S., Tiwari, S. B., & Amiji, M. M. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400605 · Cited by 146
Bennis, S., Chapey, C., Robert, J., & Couvreur, P. (1994) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80025-5 · Cited by 142
Bibby, D. C., Talmadge, J. E., Dalal, M. K., Kurz, S. G., Chytil, K. M., Barry, S. E., Shand, D. G., & Steiert, M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.021 · Cited by 133
Chiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J. P., & Couvreur, P. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02897257 · Cited by 130
Boudad, H., Legrand, P., Bas, G. L., Chéron, M., Duchêne, D., & Ponchel, G. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00622-6 · Cited by 120
Kroll, R. A., Pagel, M. A., Muldoon, L. L., Muldoon, L. L., Roman-Goldstein, S., Fiamengo, S. A., Neuwelt, E. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199810000-00090 · Cited by 118
The potential use of receptor-mediated endocytosis for oral drug delivery
Russell-Jones, G. J. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00131-p · Cited by 115
Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles
Verdun, C., Brasseur, F., Vranckx, H., Couvreur, P., & Roland, M. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02940287 · Cited by 115
Vitamin B12-mediated transport of nanoparticles across Caco-2 cells
Russell-Jones, G. J., Arthur, L., & Walker, H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00394-9 · Cited by 106
Müller, R. H., & Wallis, K. H. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90304-x · Cited by 106
Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation
Puglisi, G., Fresta, M., Giammona, G., & Ventura, C. A. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00142-6 · Cited by 95
Polymeric Nanoparticles from Rapid Expansion of Supercritical Fluid Solution
Sun, Y., Meziani, M. J., Pathak, P., & Qu, L. (2004) · Chemistry - A European Journal · doi:10.1002/chem.200400422 · Cited by 85
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Li, Y., Pei, Y., Zhou, Z.-H., Zhang, X., Gu, Z.-H., Ding, J., Zhou, J.-J., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00235-8 · Cited by 76
Björk, E., Isaksson, U., Edman, P., & Artursson, P. (1995) · Journal of drug targeting · doi:10.3109/10611869509015920 · Cited by 70
Drug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems
Pardridge, W. M. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.011 · Cited by 64
Haltner, E., Easson, J., & Lehr, C. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00096-9 · Cited by 58
CHEN, Y., MCCULLOCH, R., & GRAY, B. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90250-x · Cited by 54
Self-citationGabathuler, R., Arthur, G., Kennard, M. L., Chen, Q., Tsai, S., Yang, J., Schoorl, W., Vitalis, T., & Jefferies, W. A. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.021 · Cited by 46
The use of Pep: Trans vectors for the delivery of drugs into the central nervous system
Scherrmann, J., & Temsamani, J. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.023 · Cited by 22
Drug Delivery Across the Blood-Brain Barrier
Hartz, A. M. S., Bauer, B., Baehr, C., Miller, D. S., & Fricker, G. (2005) · Current Nanoscience · doi:10.2174/157341305774642948 · Cited by 14
Boyd, B. J. (2005) · Cited by 14
Cited by
Synthesis of metallic nanoparticles using plant extracts
Mittal, A. K., Chisti, Y., & Banerjee, U. C. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.01.003 · Cited by 2,671
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Use of iron oxide nanomaterials in wastewater treatment: A review
Xu, P., Zeng, G. M., Huang, D. L., Feng, C. L., Hu, S., Zhao, M. H., Lai, C., Wei, Z., Huang, C., Xie, G. X., et al. (2012) · Science of The Total Environment · doi:10.1016/j.scitotenv.2012.02.023 · Cited by 1,929
Therapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Subramaniam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F.-H., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,055
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Metadata
- Authors
- Mohanraj, V. J., & Chen, Y.
- Venue
- Tropical Journal of Pharmaceutical Research
- Publisher
- African Journals Online (AJOL)
- Published
- 2007-07-31
- Volume
- 5
- Issue
- 1
- ISSN
- 1596-5996 (ISSN-L)
- 1596-9827
- OpenAlex
- W2138281910
- Cited by
- 1,217
- References
- 93
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.